Frontiers Current Pharmacological Strategies for Duchenne
Por um escritor misterioso
Descrição
EMA starts review of Italfarmaco's Duchenne drug
Frontiers Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Frontiers Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata
Hypochlorous acid exposure impairs skeletal muscle function and Ca2+ signalling: implications for Duchenne muscular dystrophy pathology - Lea - 2023 - The Journal of Physiology - Wiley Online Library
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges - The Lancet Respiratory Medicine
Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Pharmaceutics, Free Full-Text
Frontiers Drug development progress in duchenne muscular dystrophy
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management - The Lancet Neurology
Emerging therapies for Duchenne muscular dystrophy - The Lancet Neurology
Current limitations of gene-targeted therapeutic strategies in DMD
Reprogramming RNA processing: an emerging therapeutic landscape: Trends in Pharmacological Sciences
de
por adulto (o preço varia de acordo com o tamanho do grupo)
